Welcome to our dedicated page for Nanalysis Sci news (Ticker: NSCIF), a resource for investors and traders seeking the latest updates and insights on Nanalysis Sci stock.
Nanalysis Scientific Corp. reports developments tied to portable Nuclear Magnetic Resonance spectrometers, MRI and imaging technology, and related services for industrial and research applications. Company updates describe instruments used in pharmaceutical, biotech, energy, food, materials, security, academic, and government settings, as well as a services division that maintains Nanalysis products and third-party imaging equipment.
Recurring news themes include quarterly and annual results, conference-call announcements, supply-chain and market-diversification updates, non-dilutive funding, private placement financings, equity incentive grants, and board composition changes. The company also references its long-term Canadian Air Transport Security Authority relationship for security-scanner maintenance at Canadian airports.
Nanalysis Scientific Corp. announced the appointment of Dr. René Lenggenhager to its Board of Directors effective January 1, 2022. Dr. Lenggenhager, a seasoned executive in global technology, will also invest $202,500 in the company through a private placement of 150,000 shares at $1.35 each. His extensive experience includes leadership roles in notable firms, focusing on high-precision technology. The investment aims to support working capital and enhance Nanalysis's product strategy in various industries. The offering is subject to TSX Venture Exchange approval and is expected to close by December 16, 2021.
Nanalysis Scientific Corp. (OTCQX: NSCIF) has announced a revised presentation time for the Fall Harvest Best Ideas conference, now scheduled from 11:30 to 12:00 ET on October 6-8, 2021. The presentation will be available via a live webcast with replay options. Management will also hold one-on-one meetings during this period, aiming to share operational updates and milestones. Nanalysis focuses on proprietary nuclear magnetic resonance (NMR) technologies, catering to various industries including oil and gas and pharmaceuticals.
Nanalysis Scientific Corp. (OTCQX:NSCIF) has announced its fall investor conference schedule with several key events planned.
It will present virtually at the Fall Harvest Best Ideas conference from October 6-8, followed by the LD Micro Main Event on October 12-13, where it will open the show.
The company will also attend the Capital Events Marketing conference in Scottsdale from October 22-24. Nanalysis aims to enhance investor engagement through one-on-one meetings during these events.
Nanalysis Scientific Corp. (OTCQX:NSCIF) will present at the 10th Annual Gateway Conference on September 9, 2021. CEO Sean Krakiwsky will provide insights at 11 a.m. Mountain Time, with one-on-one meetings to follow. The presentation will be webcast live. Nanalysis will also participate in the LD Micro Conference on October 12, 2021, at 9:30 a.m. MT, available both in-person and virtually. Company operates in nuclear magnetic resonance technologies and has established a strong market presence in various industries including pharmaceuticals and biotechnology.